LAURA DIXON: Open Payments
NPI 1992104152 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,668 in 161 payments from 21 companies in 2025. Trend: 2023 $1,737 · 2024 $2,671 · 2025 $2,668
Food & beverage: $2,668
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 33 | $691 |
| Lilly USA, LLC | 22 | $296 |
| AstraZeneca Pharmaceuticals LP | 10 | $282 |
| PFIZER INC. | 19 | $257 |
| ABBVIE INC. | 20 | $225 |
| Novartis Pharmaceuticals Corporation | 15 | $177 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $158 |
| Dexcom, Inc. | 5 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $86 |
Products named: Wegovy, NURTEC ODT, JARDIANCE, Ozempic, LEQVIO, MOUNJARO, FARXIGA, VRAYLAR.
Industry payments across FL — which companies pay providers there.
